Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Protocol

TIRB# 31322

Phase

2

Condition(s)

Idiopathic Pulmonary Fibrosis (IPF), Pulmonary Fibrosis (Including IPF), Interstitial Lung Disease (ILD)

Investigator

Gerard Criner, MD

Coordinator

Debasree Sana Boral

Visit clinicaltrials.gov for full description.